Detect genetic variants that anticipate the risk of hematological cancer associated with oncological treatments
A study coordinated by the Josep Carreras Leukemia Research Institute (IJC) has revealed that certain inherited genetic variants, present from birth, allow for the identification of patients with a higher likelihood of developing aggressive hematological cancers linked to previous cancer treatments.In some cases, individuals suffer from aggressive hematological cancers several...
5 minutos